RESprotect (RP101) Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

RESprotect (RP101) General Information

Description

RP101 drug candidate located in Dresden, Germany. The drug is an orally administered small molecule that binds to Hsp27, a chaperone protein that is found in abnormally high levels in cancer cells, and inhibits its activity as well as it is also used to treat pancreatic carcinoma.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Krippener Straße 18b
  • 01259 Dresden
  • Germany
+49 0351
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Biotechnology
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Krippener Straße 18b
  • 01259 Dresden
  • Germany
+49 0351

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RESprotect (RP101) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RESprotect (RP101)‘s full profile, request access.

Request a free trial

RESprotect (RP101) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RESprotect (RP101) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RESprotect (RP101)‘s full profile, request access.

Request a free trial

RESprotect (RP101) FAQs

  • When was RESprotect (RP101) founded?

    RESprotect (RP101) was founded in 2000.

  • Where is RESprotect (RP101) headquartered?

    RESprotect (RP101) is headquartered in Dresden, Germany.

  • What is the size of RESprotect (RP101)?

    RESprotect (RP101) has 3 total employees.

  • What industry is RESprotect (RP101) in?

    RESprotect (RP101)’s primary industry is Buildings and Property.

  • Is RESprotect (RP101) a private or public company?

    RESprotect (RP101) is a Private company.

  • What is the current valuation of RESprotect (RP101)?

    The current valuation of RESprotect (RP101) is .

  • What is RESprotect (RP101)’s current revenue?

    The current revenue for RESprotect (RP101) is .

  • Who are RESprotect (RP101)’s investors?

    RESprotect has invested in RESprotect (RP101).

  • When was RESprotect (RP101) acquired?

    RESprotect (RP101) was acquired on 14-Aug-2014.

  • Who acquired RESprotect (RP101)?

    RESprotect (RP101) was acquired by RedHill Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process